Foresee Pharmaceuticals Co., Ltd. (TPEX:6576)
79.10
0.00 (0.00%)
Apr 2, 2025, 1:30 PM CST
Foresee Pharmaceuticals Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 1,367 | 1,010 | 689.51 | 871.44 | 1,145 | Upgrade
|
Short-Term Investments | 75 | 150 | - | 100 | 125 | Upgrade
|
Trading Asset Securities | - | - | - | 297.47 | 351.68 | Upgrade
|
Cash & Short-Term Investments | 1,442 | 1,160 | 689.51 | 1,269 | 1,622 | Upgrade
|
Cash Growth | 24.37% | 68.19% | -45.66% | -21.76% | 226.86% | Upgrade
|
Accounts Receivable | 32.33 | 65.91 | 16.27 | - | - | Upgrade
|
Other Receivables | 13.76 | 22.18 | 10.13 | 5.73 | 13.97 | Upgrade
|
Receivables | 46.09 | 88.09 | 26.4 | 5.73 | 13.97 | Upgrade
|
Inventory | 183.87 | 126.8 | 176.41 | 24.88 | 34.11 | Upgrade
|
Prepaid Expenses | 145.27 | 23.56 | 22.75 | 3.9 | 9.71 | Upgrade
|
Other Current Assets | - | 192.5 | - | - | 6.62 | Upgrade
|
Total Current Assets | 1,818 | 1,591 | 915.06 | 1,303 | 1,686 | Upgrade
|
Property, Plant & Equipment | 217.62 | 135.01 | 142.39 | 91.19 | 110.8 | Upgrade
|
Other Intangible Assets | 117.79 | 126.81 | 140.96 | 155.14 | 209.44 | Upgrade
|
Long-Term Deferred Tax Assets | 1.31 | 1.23 | 1.22 | 1.1 | 1.14 | Upgrade
|
Other Long-Term Assets | 4.9 | 7.76 | 104.39 | 90.58 | 92.06 | Upgrade
|
Total Assets | 2,159 | 1,861 | 1,304 | 1,641 | 2,100 | Upgrade
|
Accounts Payable | 64.42 | 12.13 | 22.85 | - | - | Upgrade
|
Accrued Expenses | - | 120.71 | 78.47 | 61.68 | 45.8 | Upgrade
|
Short-Term Debt | 150 | 200 | - | - | 30.07 | Upgrade
|
Current Portion of Long-Term Debt | - | - | - | - | 20.79 | Upgrade
|
Current Portion of Leases | 12.41 | 15.14 | 15.52 | 10.2 | 9.38 | Upgrade
|
Current Income Taxes Payable | 8.82 | 10.42 | 4.95 | - | - | Upgrade
|
Current Unearned Revenue | 50.03 | 105.48 | 1.01 | 0.78 | 1.52 | Upgrade
|
Other Current Liabilities | 107.53 | 6.96 | 6.38 | 1.79 | 14.03 | Upgrade
|
Total Current Liabilities | 393.21 | 470.83 | 129.17 | 74.45 | 121.59 | Upgrade
|
Long-Term Debt | 92.92 | - | - | - | 63.24 | Upgrade
|
Long-Term Leases | - | 13.12 | 25.8 | 6.45 | 6.68 | Upgrade
|
Long-Term Unearned Revenue | 72.62 | 131.67 | 237.15 | 239.17 | 77.67 | Upgrade
|
Long-Term Deferred Tax Liabilities | 1.41 | 1.32 | 1.32 | 1.19 | 1.22 | Upgrade
|
Total Liabilities | 560.15 | 616.93 | 393.43 | 321.26 | 270.4 | Upgrade
|
Common Stock | 1,548 | 1,358 | 1,182 | 1,179 | 1,169 | Upgrade
|
Additional Paid-In Capital | 5,906 | 4,617 | 3,424 | 3,372 | 3,319 | Upgrade
|
Retained Earnings | -5,811 | -4,730 | -3,693 | -3,221 | -2,651 | Upgrade
|
Comprehensive Income & Other | -44.56 | -1.49 | -1.54 | -10.21 | -8.06 | Upgrade
|
Shareholders' Equity | 1,599 | 1,245 | 910.58 | 1,320 | 1,829 | Upgrade
|
Total Liabilities & Equity | 2,159 | 1,861 | 1,304 | 1,641 | 2,100 | Upgrade
|
Total Debt | 255.33 | 228.26 | 41.32 | 16.65 | 130.15 | Upgrade
|
Net Cash (Debt) | 1,187 | 931.42 | 648.19 | 1,252 | 1,492 | Upgrade
|
Net Cash Growth | 27.44% | 43.70% | -48.24% | -16.05% | 208.45% | Upgrade
|
Net Cash Per Share | 8.64 | 7.32 | 5.49 | 10.67 | 14.71 | Upgrade
|
Filing Date Shares Outstanding | 140.88 | 135.82 | 118.17 | 117.94 | 116.94 | Upgrade
|
Total Common Shares Outstanding | 140.88 | 135.82 | 118.17 | 117.94 | 116.94 | Upgrade
|
Working Capital | 1,424 | 1,120 | 785.89 | 1,229 | 1,565 | Upgrade
|
Book Value Per Share | 11.35 | 9.16 | 7.71 | 11.19 | 15.64 | Upgrade
|
Tangible Book Value | 1,481 | 1,118 | 769.62 | 1,165 | 1,620 | Upgrade
|
Tangible Book Value Per Share | 10.51 | 8.23 | 6.51 | 9.88 | 13.85 | Upgrade
|
Machinery | - | 209.45 | 171.58 | 136.94 | 144.58 | Upgrade
|
Construction In Progress | - | 4.9 | 20.39 | 4.4 | 1.31 | Upgrade
|
Leasehold Improvements | - | 30.44 | 7.71 | 7.71 | 7.71 | Upgrade
|
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.